Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
Market Development Veteran Lisa Rogan Joins Nuvaira's Executive Team
MINNEAPOLIS, Feb. 11, 2019 -- (Healthcare Sales & Marketing Network) -- Nuvaira, a developer of novel therapeutic medical devices to treat obstructive lung diseases, announced today ... Devices, Venture Capital, Personnel Nuvaira, Lung Denervation, Targeted Lung Denervation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Chronic Obstructive Pulmonary | Marketing | Medical Devices | Pharmaceuticals | Venture Capital